FDA clears Intuitive Surgical’s ‘fifth-generation robotic’ da Vinci 5

Intuitive announced that the U.S. Food and Drug Administration FDA provided 510k clearance for da Vinci 5, the company’s next-generation multiport robotic system.”We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5,” said Gary Guthart, CEO. “Intuitive is committed to meaningful improvements in surgery that enable better patient outcomes, enhance the patient and care team experiences, and ultimately lower the total cost of care. After more than a decade of careful research, design, development, and testing, we believe da Vinci 5 will deliver on these goals and help drive the future of robotic-assisted surgery.” Da Vinci 5 builds on Intuitive’s da Vinci Xi’s highly functional design, which surgeons and care teams around the world have used in more than 7 million procedures to date.